Shuzhidao Hair Transplant Robot

The Shuzhidao Hair Transplant Robot represents China’s first domestically developed automated hair restoration system to achieve NMPA approval. Employing high-definition stereoscopic imaging, visual servo technology, and a proprietary six-axis robotic arm, the system achieves positioning accuracy of 0.1mm while utilizing micro-needle technology that minimizes tissue trauma compared to conventional approaches.

Product Overview

Hair transplantation using Follicular Unit Extraction (FUE) technique demands prolonged precision work from surgeons, who must maintain consistent extraction force and angle across thousands of individual follicles during procedures lasting several hours. This creates significant fatigue risk that can affect procedure outcomes. The Shuzhidao system automates the extraction phase through robotic control, maintaining consistent performance while reducing physician workload.

The system completed multi-center registration clinical trials at institutions including Zhejiang University School of Medicine affiliated Hangzhou First People’s Hospital before receiving regulatory approval. Clinical trial data demonstrated safety with no robot-related adverse events and follicular survival rates reaching 95%.

Key Features

Shuzhidao’s Hair Transplant Robot is China’s first NMPA-approved automated FUE system, achieving 0.1mm follicle targeting and a 95% survival rate in clinical trials.

0.1mm Positioning Precision: The visual servo system employs high-definition stereoscopic cameras to locate each target follicle with sub-millimeter accuracy. AI algorithms identify optimal extraction candidates based on follicle orientation, diameter, and surrounding tissue characteristics.

Micro-Needle Technology: Unlike international systems requiring instruments with external diameters exceeding 1mm, the Shuzhidao system uses needle tips smaller than 1mm. The reduced instrument diameter creates minimal scalp trauma, accelerating wound healing and reducing post-operative discomfort.

Non-Invasive Tensioning: Competing systems require installation of complex tensioning devices that create tissue trauma. The Shuzhidao approach achieves necessary scalp stabilization through a non-invasive method completed within 30 seconds during procedure setup.

Silent Operation: The system operates with minimal acoustic output, reducing patient anxiety and creating a more comfortable surgical environment for both patients and clinical staff.

Technical Specifications

China’s first approved automated hair transplant robot, this system extracts follicles at 0.1mm precision using HD stereoscopic vision and a needle tip smaller than 1mm to reduce scalp trauma.

Clinical Applications

The hair transplant robot addresses male pattern baldness (androgenetic alopecia) through automated FUE extraction. The system is suitable for patients across Hamilton-Norwood classification stages who are candidates for follicular unit transplantation.

Procedure Workflow: Surgeons operate the system from a high-definition touchscreen interface rather than maintaining prolonged physical positioning at the patient’s side. The robot automatically identifies and extracts target follicles according to the pre-operative plan, with the physician monitoring progress and adjusting parameters as needed.

Efficiency Gains: By automating the most labor-intensive phase of FUE procedures, the system reduces overall surgical time while eliminating physician fatigue as a variable affecting extraction quality. Multiple procedures can be performed daily without the cumulative performance degradation seen with manual techniques.

Competitive Positioning

The Shuzhidao system enters a market previously dominated by the ARTAS system from Restoration Robotics. Key differentiators include the smaller instrument diameter, non-invasive tensioning approach, and fully domestic development enabling potential cost advantages in the Chinese market.

China’s hair transplant market shows unusually high penetration compared to other Asian countries, with a 0.21% procedure rate significantly exceeding Japan’s 0.04%. This market dynamic, combined with growing consumer acceptance of robotic-assisted procedures, positions automated systems for continued adoption growth.

Regulatory Status

The system received NMPA approval following completion of multi-center randomized controlled clinical trials evaluating safety and efficacy in patients with androgenetic alopecia.

Commercial Deployment

The hair transplant robot has completed commercial cases at institutions including:

• Shao Yifu International Medical Center (under Dr. Zhou Qiang)
• Zhejiang University School of Medicine affiliated Hangzhou First People’s Hospital (under Prof. Zhang Jufang)

Early commercial procedures have demonstrated the system’s performance in real-world clinical settings, with cases requiring approximately 2,000 follicular unit extractions completed successfully.

Frequently Asked Questions

What conditions can the Shuzhidao Hair Transplant Robot treat?

The robot is designed for follicular unit extraction in patients with androgenetic alopecia (male pattern baldness). It automates the extraction phase of FUE hair transplant procedures, suitable for patients across various Hamilton-Norwood classification stages.

How does this compare to the ARTAS hair transplant robot?

The Shuzhidao system differentiates through smaller needle diameter (<1mm vs >1mm), non-invasive tensioning methods, and fully domestic development. The company claims reduced tissue trauma leading to faster healing and higher follicular survival rates. Direct comparative clinical data between systems is not yet available.

What is the expected follicle survival rate?

Clinical trial data indicates follicular survival rates of 95% with the Shuzhidao system. Individual results depend on multiple factors including patient characteristics, recipient site preparation, and post-operative care.

How long does a robot-assisted hair transplant procedure take?

Procedure duration depends on the number of grafts required. The robotic system increases extraction efficiency compared to manual FUE, though total procedure time also includes recipient site preparation and graft placement phases that may remain manual.